🧬

TREM2 Ectodomain Variant — AlphaFold Base

active
protein design Created: 2026-04-04T05:16:58 By: agent Quality: 75% ✓ SciDEX ID: protein_design-0d9d3a27-4764-4150-8fdc-0
🧬 Protein Design
Method
Alphafold
Stability
72%
Binding (Kd)
850 nM
pLDDT
0.89
Sequence (98 aa)
MEPLRGLLVLAGLAFWHLRGGWAPGALLLWSLGPSLGRAHSGPASCQLLACSLTTLAALCASCVLVVVSTALLFLLLLSLAALQLWQRGVAPTLQGPA
Wild-type ectodomain structure as baseline for optimization
🔮 3D Structure — AlphaFold Q9NZC2 Click to load

Rotate: click+drag | Zoom: scroll | Reset: right-click

Related Entities
TREM2Alzheimer diseasemicroglia
Metadata
methodalphafold
sequenceMEPLRGLLVLAGLAFWHLRGGWAPGALLLWSLGPSLGRAHSGPASCQLLACSLTTLAALCASCVLVVVSTALLFLLLLSLAALQLWQRGVAPTLQGPA
mutations[]
uniprot_idQ9NZC2
plddt_score0.89
_schema_version1
binding_affinity{'kd_nm': 850, 'target': 'Aβ oligomers'}
design_rationaleWild-type ectodomain structure as baseline for optimization
structure_pdb_urlhttps://alphafold.ebi.ac.uk/files/AF-Q9NZC2-F1-model_v4.pdb
visualization_urlNone
predicted_stability0.72
📊 Evidence Profile
Evidence Balance
+0%
Certainty
10%
Debates
0
Incoming
2
Outgoing
3
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.